---
title: "SPC released its 2024 annual performance, turning from profit to a loss of 378 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236450865.md"
description: "According to the Zhitong Finance APP, SPC released its annual report for 2024. During the reporting period, the company achieved operating revenue of 8.716 billion yuan, a year-on-year increase of 1.18%. The net loss attributable to shareholders of the listed company was 378 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 411 million yuan. The basic loss per share was 0.269 yuan"
datetime: "2025-04-17T14:21:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236450865.md)
  - [en](https://longbridge.com/en/news/236450865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236450865.md)
generator: "portal-rs"
---

# SPC released its 2024 annual performance, turning from profit to a loss of 378 million yuan

According to the Zhitong Finance APP, SPC (002573.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 8.716 billion yuan, a year-on-year increase of 1.18%. The net loss attributable to shareholders of the listed company was 378 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 411 million yuan. The basic loss per share was 0.269 yuan

### Related Stocks

- [002573.CN](https://longbridge.com/en/quote/002573.CN.md)

## Related News & Research

- [REG - Windar Photonics PLC - Holding(s) in Company](https://longbridge.com/en/news/297772032.md)
- [Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and Individualized Clinical Care](https://longbridge.com/en/news/297951968.md)
- [PPC Flex Announces Strategic Acquisition of Koen Pack](https://longbridge.com/en/news/297929336.md)
- [NewHydrogen, UCSB file third provisional patent for ThermoLoop hydrogen process](https://longbridge.com/en/news/297613273.md)
- [02:00 ETArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026](https://longbridge.com/en/news/297995914.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**